+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Attention Deficit Hyperactivity Disorder Market Size, Share & Trends Analysis Report By Drug Type (Stimulants, Non-stimulants), By Demographics (Children, Adults), By Distribution Channel, By Region, And Segment Forecasts, 2023 - 2030

  • PDF Icon

    Report

  • 114 Pages
  • November 2022
  • Region: Global
  • Grand View Research
  • ID: 5230055
Description Jump to:

Quick Summary:

In a market constantly in motion, the right information can make the critical difference in gaining a competitive edge. Detailed, accurate, and actionable information leads to well-informed decisions, and our market research report on the global attention deficit hyperactivity disorder (ADHD) provides precisely that. A sector undergoing impressive expansion, it is consistently fueled by a strong product pipeline designed for ADHD treatments and approvals. Companies like Neurocentria, Supernus Pharmaceuticals, and Otsuka America Pharmaceutical are in the late-stage pipeline, driving progress and innovation in this field.

Government initiatives are also a vital factor in this market's growth, with concerted efforts aimed at early ADHD diagnosis and treatment. One such initiative led to the widespread, subsidized availability of Vyvanse in Australia, thereby providing affordable treatment to over 20,000 patients annually. Growing awareness of ADHD among patients, physicians, and other healthcare providers is anticipated to further drive the demand for diagnosis and treatment, propelling the ADHD market's growth. Complementing this, organizations such as the Attention Deficit Hyperactivity Disorder Coaches Organization (ACO) work tirelessly to raise awareness and further educate the public about ADHD, spurring early diagnoses and increased product penetration.

However, it's crucial to note, the ADHD market has its challenges, with patients affected by comorbidity psychiatric disorders often avoiding medication use and treatment. In addition, a shortage of ADHD treatment stimulants has led to a rise in alternative substitute therapies, potentially deterring demand for pharmacological ADHD therapies. This comprehensive market research report charts the waters of these challenges and opportunities, asserting its value to any stakeholder in the global ADHD market.

The global attention deficit hyperactivity disorder market size is expected to reach USD 18.69 billion by 2030. The market is expected to expand at a CAGR of 4.2% from 2023 to 2030. The presence of a strong product pipeline for the treatment of ADHD and their subsequent approval is expected to boost the market growth. Some late-stage pipeline products are NRCT-101 developed by Neurocentria, Inc., SPN-812 by Supernus Pharmaceuticals, Inc., and EB-1020 by Otsuka America Pharmaceutical, Inc.

Several initiatives undertaken by government bodies regarding early diagnosis and treatment of ADHD are likely to support the market growth. In January 2021, the Australian Government included Vyvanse under its Pharmaceutical Benefits Scheme (PBS) for the treatment of adult patients with ADHD. This inclusion makes the availability of Vyvanse at a subsidized rate to patients and more than 20,000 patients received a comparable treatment for the disease at low cost and benefits. Without PBS subsidy, the patients had to pay more than USD 1,200 per person annually for their treatment. After the inclusion in PBS, they will receive the treatment at USD 41.30 per script. Such initiatives are also expected to drive market growth.

Increasing awareness about ADHD among patients, physicians, and other healthcare providers may increase the demand for diagnosis and treatment which in turn propel the growth of the attention deficit hyperactivity disorder market. The Attention Deficit Hyperactivity Disorder Coaches Organization (ACO) celebrates October as the ADHD awareness month intending to raise awareness, generate funding for R&D, and educate people about disorders. This initiative may boost early diagnosis, thereby, increasing product penetration.

However, the risk of comorbidity with other psychiatric disorders is high among children with ADHD, often making diagnosis and treatment of the disorder complex. A research study published by the Lundbeck Foundation in 2021 showed that ADHD patients with other psychiatric comorbid conditions were more likely to avoid taking medicines. Some of the comorbid conditions that typically occur in ADHD pediatric patients are depression, anxiety, bipolar disorder, learning disorder, early speech/communication problems, and oppositional defiant disorder.

Furthermore, the shortage of stimulants to treat ADHD has forced patients to pay for expensive branded medication and create scope for substitute therapies, such as behavioral therapy, which will negatively impact the demand for ADHD pharmacological therapies. Strict regulations are implemented by regulatory bodies, such as the U.S. Drug Enforcement Administration (DEA), which limit the production of ADHD drugs to avoid misuse or abuse. Amid an increase in demand, this can create a shortage of medical products, consequently increasing the cost of treatments and restraining market growth. Thus, the shortage of medicines may impede the market growth.

Attention Deficit Hyperactivity Disorder Market Report Highlights

  • By drug type, the stimulants segment accounted for the largest share of the market in 2022 due to the high demand for these medicines and the management of symptoms, government support for the use of stimulants drugs, and continuing clinical trials regarding attention deficit hyperactive disorder
  • Based on demographics, the adults segment dominated the attention-deficit hyperactivity disorder market in 2022 owing to the large target population base and high risk of developing the attention-deficit hyperactive disorder. According to ADD Health and Wellness Centers, Inc. the disorder affects approximately 4-5% of the adult population
  • Retail pharmacy segment dominated the attention-deficit hyperactivity disorder market in 2022 and is anticipated to witness the fastest growth over the forecast period. This can be attributed to the wide availability of attention deficit hyperactivity disorder drugs at retail pharmacies and their ease of accessibility to patients
  • North America dominated the global market in 2022 owing to factors such as high awareness among healthcare professionals about drugs available for treatment and the rise in disease prevalence. According to the Center for ADHD Awareness Canada (CADDAC), more than 1.5 million people are affected by the disease in Canada
  • Asia Pacific is expected to be the fastest-growing region during the forecast period to increasing ADHD prevalence and treatment demand in the region. For instance, ADHD is one of the most common neurodevelopment diseases with approximately 8.2% of children and 11% of boys diagnosed in Australia


This product will be delivered within 1-3 business days.
Frequently Asked Questions about the Global Attention Deficit Hyperactivity Disorder Market

What is the estimated value of the Global Attention Deficit Hyperactivity Disorder Market?

The Global Attention Deficit Hyperactivity Disorder Market was estimated to be valued at $13.97 Billion in 2022.

What is the growth rate of the Global Attention Deficit Hyperactivity Disorder Market?

The growth rate of the Global Attention Deficit Hyperactivity Disorder Market is 4.2%, with an estimated value of $18.69 Billion by 2030.

What is the forecasted size of the Global Attention Deficit Hyperactivity Disorder Market?

The Global Attention Deficit Hyperactivity Disorder Market is estimated to be worth $18.69 Billion by 2030.

Who are the key companies in the Global Attention Deficit Hyperactivity Disorder Market?

Key companies in the Global Attention Deficit Hyperactivity Disorder Market include Pfizer, Inc., Johnson & Johnson Services, Inc., Lupin, Novartis AG, Takeda Pharmaceutical Company Limited, Mallinckrodt plc., Purdue Pharma L.P., Neos Therapeutics, Inc. and Supernus Pharmaceuticals, Inc..
Report AttributeDetails
No. of Pages114
PublishedNovember 2022
Forecast Period2022 - 2030
Estimated Market Value ( USD ) in 2022 $ 13.97 Billion
Forecasted Market Value ( USD ) by 2030 $ 18.69 Billion
Compound Annual Growth Rate4.2%
Regions CoveredGlobal
No. of Companies Mentioned9

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market Segmentation and Scope
1.1.1 Segment scope
1.1.2 Regional scope
1.1.3 Estimates and forecast timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased database:
1.3.2 internal database
1.3.3 Secondary sources
1.3.4 Primary research
1.3.5 Details of primary research
1.4 Information or Data Analysis
1.4.1 Data analysis models
1.5 Market Formulation and Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach: Commodity Flow Approach
1.7 Research Assumptions
1.8 List of Secondary Sources
1.9 List of Abbreviations
1.10 Objectives
1.10.1 Objective 1
1.10.2 Objective 2
1.10.3 Objective 3
1.10.4 Objective 4
Chapter 2 Executive Summary
2.1 Market Snapshot
2.2 Segment Snapshot
2.3 Competitive Snapshot
Chapter 3 Attention Deficit Hyperactivity Disorder: Market Variables, Trends, and Scope
3.1 Market Lineage Outlook
3.1.1 Central Nervous System Therapeutics Market
3.2 Penetration and Growth Prospect Mapping
3.3 Regulatory Landscape
3.4 Market Dynamics
3.5 Market Driver Analysis
3.5.1 Increasing Prevalence of ADHD
3.5.2 Increasing Awareness About ADHD Among Physicians and Patients
3.6 Market Restraint Analysis
3.6.1 Shortage of ADHD Drugs
3.6.2 Low Availability of Non-stimulant ADHD Drugs
3.6.3 Comorbidities Leading to Underdiagnosis in Children
3.7 PESTEL Analysis
3.8 Industry Analysis - Porter’s Five Forces
3.9 Pipeline Analysis
Chapter 4 Attention Deficit Hyperactivity Disorder Market: Segment Analysis, by Drug Type, 2018 - 2030 (USD Million)
4.1 Attention Deficit Hyperactivity Disorder Market: Drug Type Movement Analysis
4.2 Stimulants
4.2.1 Stimulants Market, 2018 - 2030 (USD Million)
4.2.2 Amphetamine
4.2.2.1 Amphetamine Market, 2018 - 2030 (USD Million)
4.2.3 Methylphenidate
4.2.3.1 Methylphenidate Market, 2018 - 2030 (USD Million)
4.2.4 Lisdexamfetamine
4.2.4.1 Lisdexamfetamine Market, 2018 - 2030 (USD Million)
4.2.5 Dexmethylphenidate
4.2.5.1 Dexmethylphenidate Market, 2018 - 2030 (USD Million)
4.3 Non - Stimulants
4.3.1 Non - stimulants Market, 2018 - 2030 (USD Million)
4.3.2 Atomoxetine
4.3.2.1 Atomoxetine Market, 2018 - 2030 (USD Million)
4.3.3 Guanfacine
4.3.3.1 Guanfacine Market, 2018 - 2030 (USD Million)
4.3.4 Clonidine
4.3.4.1 Clonidine Market, 2018 - 2030 (USD Million)
4.3.5 Others
4.3.5.1 Others Market, 2018 - 2030 (USD Million)
Chapter 5 Attention Deficit Hyperactivity Disorder Market: Segment Analysis, by Demographic, 2018 - 2030 (USD Million)
5.1 Attention Deficit Hyperactivity Disorder Market: Demographics Movement Analysis
5.2 Children
5.2.1 Children Market, 2018 - 2030 (USD Million)
5.3 Adults
5.3.1 Adult Market, 2018 - 2030 (USD Million)
Chapter 6 Attention Deficit Hyperactivity Disorder Market: Segment Analysis, by Distribution Channel, 2018 - 2030 (USD Million)
6.1 Attention Deficit Hyperactivity Disorder Market: Distribution Channel Movement Analysis
6.2 Retail Pharmacy
6.2.1 Retail Pharmacy Market, 2018 - 2030 (USD Million)
6.3 Hospital Pharmacy
6.3.1 Hospital Pharmacy Market, 2018 - 2030 (USD Million)
Chapter 7 Attention Deficit Hyperactivity Disorder Market: Segment Analysis, by Region, 2018 - 2030 (USD Million)
7.1 Regional Market Snapshot
7.2 Regional Market Share Analysis, 2022 & 2030
7.3 Market Size, Forecasts, and Revenue & Trend Analysis, 2022 to 2030
7.3.1 North America
7.3.1.1 North America Attention Deficit Hyperactivity Disorder Market Estimates and Forecast, 2018 - 2030 (USD Million)
7.3.1.2 U.S.
7.3.1.2.1 U.S. Attention Deficit Hyperactivity Disorder Market Estimates and Forecast, 2018 - 2030 (USD Million)
7.3.1.3 Canada
7.3.1.3.1 Canada Attention Deficit Hyperactivity Disorder Market Estimates and Forecast, 2018 - 2030 (USD Million)
7.3.2 Europe
7.3.2.1 Europe Attention Deficit Hyperactivity Disorder Market Estimates and Forecast, 2018 - 2030 (USD Million)
7.3.2.2 UK
7.3.2.2.1 UK Attention Deficit Hyperactivity Disorder Market Estimates and Forecast, 2018 - 2030 (USD Million)
7.3.2.3 Germany
7.3.2.3.1 Germany Attention Deficit Hyperactivity Disorder Market Estimates and Forecast, 2018 - 2030 (USD Million)
7.3.2.4 Spain
7.3.2.4.1 Spain Attention Deficit Hyperactivity Disorder Market Estimates and Forecast, 2018 - 2030 (USD Million)
7.3.2.5 France
7.3.2.5.1 France Attention Deficit Hyperactivity Disorder Market Estimates and Forecast, 2018 - 2030 (USD Million)
7.3.2.6 Italy
7.3.2.6.1 Italy Attention Deficit Hyperactivity Disorder Market Estimates and Forecast, 2018 - 2030 (USD Million)
7.3.3 Asia Pacific
7.3.3.1 Asia Pacific Attention Deficit Hyperactivity Disorder Market Estimates and Forecast, 2018 - 2030 (USD Million)
7.3.3.2 Japan
7.3.3.2.1 Japan Attention Deficit Hyperactivity Disorder Market Estimates and Forecast, 2018 - 2030 (USD Million)
7.3.3.3 China
7.3.3.3.1 China Attention Deficit Hyperactivity Disorder Market Estimates and Forecast, 2018 - 2030 (USD Million)
7.3.3.4 India
7.3.3.4.1 India Attention Deficit Hyperactivity Disorder Market Estimates and Forecast, 2018 - 2030 (USD Million)
7.3.3.5 Australia
7.3.3.5.1 Australia Attention Deficit Hyperactivity Disorder Market Estimates and Forecast, 2018 - 2030 (USD Million)
7.3.3.6 South Korea
7.3.3.6.1 South Korea Attention Deficit Hyperactivity Disorder Market Estimates and Forecast, 2018 - 2030 (USD Million)
7.3.4 Latin America
7.3.4.1 Latin America Attention Deficit Hyperactivity Disorder Market Estimates and Forecast, 2018 - 2030 (USD Million)
7.3.4.2 Brazil
7.3.4.2.1 Brazil Attention Deficit Hyperactivity Disorder Market Estimates and Forecast, 2018 - 2030 (USD Million)
7.3.4.3 Mexico
7.3.4.3.1 Mexico Attention Deficit Hyperactivity Disorder Market Estimates and Forecast, 2018 - 2030 (USD Million)
7.3.4.4 Argentina
7.3.4.4.1 Argentina Attention Deficit Hyperactivity Disorder Market Estimates and Forecast, 2018 - 2030 (USD Million)
7.3.5 MEA
7.3.5.1 MEA Attention Deficit Hyperactivity Disorder Market Estimates and Forecast, 2018 - 2030 (USD Million)
7.3.5.2 South Africa
7.3.5.2.1 South Africa Attention Deficit Hyperactivity Disorder Market Estimates and Forecast, 2018 - 2030 (USD Million)
7.3.5.3 Saudi Arabia
7.3.5.3.1 Saudi Arabia Attention Deficit Hyperactivity Disorder Market Estimates and Forecast, 2018 - 2030 (USD Million)
7.3.5.4 UAE
7.3.5.4.1 UAE Attention Deficit Hyperactivity Disorder Market Estimates and Forecast, 2018 - 2030 (USD Million)
Chapter 8 Attention Deficit Hyperactivity Disorder Market: Competitive Analysis
8.1 Recent Developments and Impact Analysis, by Key Market Participants
8.1.1 Synergy Analysis: Major Deals and Strategic Alliances
8.1.1.1 New Product Launches
8.1.1.2 Mergers and Acquisitions
8.1.1.3 Licensing Agreements
8.2 Company Categorization
8.2.1 Innovators
8.2.2 Market Leaders
8.2.3 Emerging Players
8.2.4 Heat Map Analysis
8.3 Company Market Position Analysis
8.4 Vendor Landscape
8.4.1 List of Key Distributors and Channel Partners
8.4.2 List of Potential End-Users
8.4.3 Key Company Market Share Analysis, 2022
8.4.4 Consumer Behavior Analysis
8.4.5 Competitive Dashboard Analysis
8.5 Private Companies
8.5.1 List of Key Emerging Companies
8.5.2 Regional Network Map
8.6 Company Profiles
8.6.1 Pfizer, Inc.
8.6.1.1 Company Overview
8.6.1.2 Financial Performance
8.6.1.3 Product Benchmarking
8.6.1.4 Recent Developments
8.6.2 Johnson & Johnson Services, Inc.
8.6.2.1 Company Overview
8.6.2.2 Financial Performance
8.6.2.3 Product Benchmarking
8.6.2.4 Recent Developments
8.6.3 Lupin
8.6.3.1 Company Overview
8.6.3.2 Financial Performance
8.6.3.3 Product Benchmarking
8.6.3.4 Recent Developments
8.6.4 Novartis AG
8.6.4.1 Company Overview
8.6.4.2 Financial Performance
8.6.4.3 Product Benchmarking
8.6.4.4 Recent Developments
8.6.5 Takeda Pharmaceutical Company Limited
8.6.5.1 Company Overview
8.6.5.2 Shire plc
8.6.5.3 Financial Performance
8.6.5.4 Product Benchmarking
8.6.5.5 Recent Developments
8.6.6 Mallinckrodt plc.
8.6.6.1 Company Overview
8.6.6.2 Financial Performance
8.6.6.3 Product Benchmarking
8.6.7 Purdue Pharma L.p.
8.6.7.1 Company Overview
8.6.7.2 Product Benchmarking
8.6.8 NEOS Therapeutics, Inc.
8.6.8.1 Company Overview
8.6.8.2 Financial performance
8.6.8.3 Product Benchmarking
8.6.8.4 Recent Developments
8.6.9 Supernus Pharmaceuticals, Inc.
8.6.9.1 Company Overview
8.6.9.2 Financial performance
8.6.9.3 Product Benchmarking
8.6.9.4 Recent Developments
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Regulatory Framework
Table 4 FDA-approved Amphetamine Drugs for ADHD
Table 5 5 FDA-approved Methylphenidate Drugs for ADHD
Table 6 FDA-Approved Non-Stimulants Drugs for ADHD
Table 7 Wholesale Prices of Prescription ADHD Medications
Table 8 List of Parameters
Table 9 List of Distributors
Table 10 Global Attention Deficit Hyperactivity Disorder Market, By Region, 2018 - 2030 (USD Million)
Table 11 Global Attention Deficit Hyperactivity Disorder Market, By Demographics, 2018 - 2030 (USD Million)
Table 12 Global Attention Deficit Hyperactivity Disorder Market, By Drug Type, 2018 - 2030 (USD Million)
Table 13 Global Attention Deficit Hyperactivity Disorder Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 14 North America Attention Deficit Hyperactivity Disorder Market, By Country, 2018 - 2030 (USD Million)
Table 15 North America Attention Deficit Hyperactivity Disorder Market, By Demographics, 2018 - 2030 (USD Million)
Table 16 North America Attention Deficit Hyperactivity Disorder Market, By Drug Type, 2018 - 2030 (USD Million)
Table 17 North America Attention Deficit Hyperactivity Disorder Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 18 U.S. Attention Deficit Hyperactivity Disorder Market, By Demographics, 2018 - 2030 (USD Million)
Table 19 U.S. Attention Deficit Hyperactivity Disorder Market, By Drug Type, 2018 - 2030 (USD Million)
Table 20 U.S. Attention Deficit Hyperactivity Disorder Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 21 Canada Attention Deficit Hyperactivity Disorder Market, By Demographics, 2018 - 2030 (USD Million)
Table 22 Canada Attention Deficit Hyperactivity Disorder Market, By Drug Type, 2018 - 2030 (USD Million)
Table 23 Canada Attention Deficit Hyperactivity Disorder Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 24 Europe Attention Deficit Hyperactivity Disorder Market, By Country, 2018 - 2030 (USD Million)
Table 25 Europe Attention Deficit Hyperactivity Disorder Market, By Demographics, 2018 - 2030 (USD Million)
Table 26 Europe Attention Deficit Hyperactivity Disorder Market, By Drug Type, 2018 - 2030 (USD Million)
Table 27 Europe Attention Deficit Hyperactivity Disorder Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 28 Germany Attention Deficit Hyperactivity Disorder Market, By Demographics, 2018 - 2030 (USD Million)
Table 29 Germany Attention Deficit Hyperactivity Disorder Market, By Drug Type, 2018 - 2030 (USD Million)
Table 30 Germany Attention Deficit Hyperactivity Disorder Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 31 UK Attention Deficit Hyperactivity Disorder Market, By Demographics, 2018 - 2030 (USD Million)
Table 32 UK Attention Deficit Hyperactivity Disorder Market, By Drug Type, 2018 - 2030 (USD Million)
Table 33 UK Attention Deficit Hyperactivity Disorder Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 34 France Attention Deficit Hyperactivity Disorder Market, By Demographics, 2018 - 2030 (USD Million)
Table 35 France Attention Deficit Hyperactivity Disorder Market, By Drug Type, 2018 - 2030 (USD Million)
Table 36 France Attention Deficit Hyperactivity Disorder Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 37 Italy Attention Deficit Hyperactivity Disorder Market, By Demographics, 2018 - 2030 (USD Million)
Table 38 Italy Attention Deficit Hyperactivity Disorder Market, By Drug Type, 2018 - 2030 (USD Million)
Table 39 Italy Attention Deficit Hyperactivity Disorder Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 40 Spain Attention Deficit Hyperactivity Disorder Market, By Demographics, 2018 - 2030 (USD Million)
Table 41 Spain Attention Deficit Hyperactivity Disorder Market, By Drug Type, 2018 - 2030 (USD Million)
Table 42 Spain Attention Deficit Hyperactivity Disorder Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 43 Asia Pacific Attention Deficit Hyperactivity Disorder Market, By Country, 2018 - 2030 (USD Million)
Table 44 Asia Pacific Attention Deficit Hyperactivity Disorder Market, By Demographics, 2018 - 2030 (USD Million)
Table 45 Asia Pacific Attention Deficit Hyperactivity Disorder Market, By Drug Type, 2018 - 2030 (USD Million)
Table 46 Asia Pacific Attention Deficit Hyperactivity Disorder Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 47 Japan Attention Deficit Hyperactivity Disorder Market, By Demographics, 2018 - 2030 (USD Million)
Table 48 Japan Attention Deficit Hyperactivity Disorder Market, By Drug Type, 2018 - 2030 (USD Million)
Table 49 Japan Attention Deficit Hyperactivity Disorder Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 50 China Attention Deficit Hyperactivity Disorder Market, By Demographics, 2018 - 2030 (USD Million)
Table 51 China Attention Deficit Hyperactivity Disorder Market, By Drug Type, 2018 - 2030 (USD Million)
Table 52 China Attention Deficit Hyperactivity Disorder Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 53 India Attention Deficit Hyperactivity Disorder Market, By Demographics, 2018 - 2030 (USD Million)
Table 54 India Attention Deficit Hyperactivity Disorder Market, By Drug Type, 2018 - 2030 (USD Million)
Table 55 India Attention Deficit Hyperactivity Disorder Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 56 South Korea Attention Deficit Hyperactivity Disorder Market, By Demographics, 2018 - 2030 (USD Million)
Table 57 South Korea Attention Deficit Hyperactivity Disorder Market, By Drug Type, 2018 - 2030 (USD Million)
Table 58 South Korea Attention Deficit Hyperactivity Disorder Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 59 Australia Attention Deficit Hyperactivity Disorder Market, By Demographics, 2018 - 2030 (USD Million)
Table 60 Australia Attention Deficit Hyperactivity Disorder Market, By Drug Type, 2018 - 2030 (USD Million)
Table 61 Australia Attention Deficit Hyperactivity Disorder Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 62 Latin America Attention Deficit Hyperactivity Disorder Market, By Country, 2018 - 2030 (USD Million)
Table 63 Latin America Attention Deficit Hyperactivity Disorder Market, By Demographics, 2018 - 2030 (USD Million)
Table 64 Latin America Attention Deficit Hyperactivity Disorder Market, By Drug Type, 2018 - 2030 (USD Million)
Table 65 Latin America Attention Deficit Hyperactivity Disorder Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 66 Brazil Attention Deficit Hyperactivity Disorder Market, By Demographics, 2018 - 2030 (USD Million)
Table 67 Brazil Attention Deficit Hyperactivity Disorder Market, By Drug Type, 2018 - 2030 (USD Million)
Table 68 Brazil Attention Deficit Hyperactivity Disorder Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 69 Mexico Attention Deficit Hyperactivity Disorder Market, By Demographics, 2018 - 2030 (USD Million)
Table 70 Mexico Attention Deficit Hyperactivity Disorder Market, By Drug Type, 2018 - 2030 (USD Million)
Table 71 Mexico Attention Deficit Hyperactivity Disorder Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 72 Argentina Attention Deficit Hyperactivity Disorder Market, By Demographics, 2018 - 2030 (USD Million)
Table 73 Argentina Attention Deficit Hyperactivity Disorder Market, By Drug Type, 2018 - 2030 (USD Million)
Table 74 Argentina Attention Deficit Hyperactivity Disorder Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 75 Middle East & Africa Attention Deficit Hyperactivity Disorder Market, By Country, 2018 - 2030 (USD Million)
Table 76 Middle East & Africa Attention Deficit Hyperactivity Disorder Market, By Demographics, 2018 - 2030 (USD Million)
Table 77 Middle East & Africa Attention Deficit Hyperactivity Disorder Market, By Drug Type, 2018 - 2030 (USD Million)
Table 78 Middle East & Africa Attention Deficit Hyperactivity Disorder Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 79 Saudi Arabia Attention Deficit Hyperactivity Disorder Market, By Demographics, 2018 - 2030 (USD Million)
Table 80 Saudi Arabia Attention Deficit Hyperactivity Disorder Market, By Drug Type, 2018 - 2030 (USD Million)
Table 81 Saudi Arabia Attention Deficit Hyperactivity Disorder Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 82 South Africa Attention Deficit Hyperactivity Disorder Market, By Demographics, 2018 - 2030 (USD Million)
Table 83 South Africa Attention Deficit Hyperactivity Disorder Market, By Drug Type, 2018 - 2030 (USD Million)
Table 84 South Africa Attention Deficit Hyperactivity Disorder Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 85 UAE Attention Deficit Hyperactivity Disorder Market, By Demographics, 2018 - 2030 (USD Million)
Table 86 UAE Attention Deficit Hyperactivity Disorder Market, By Drug Type, 2018 - 2030 (USD Million)
Table 87 UAE Attention Deficit Hyperactivity Disorder Market, By Distribution Channel, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Attention Deficit Hyperactivity Disorder (ADHD) Market Segmentation
Fig. 2 Market Research Process
Fig. 3 Information Procurement
Fig. 4 Primary Research Pattern
Fig. 5 Market Research Approaches
Fig. 6 Value Chain-based Sizing & Forecasting
Fig. 7 QFD Modeling for Market Share Assessment
Fig. 8 Market Formulation & Validation
Fig. 9 Commodity Flow Approach
Fig. 10 Market Snapshot (2022) (USD Million)
Fig. 11 Segment Snapshot (2022) (USD Million)
Fig. 12 Competitive Snapshot
Fig. 13 Penetration & Growth Prospect Mapping
Fig. 14 ADHD Market Driver Impact
Fig. 15 ADHD Market Restraint Impact
Fig. 16 PESTEL Analysis
Fig. 17 Porter’s Five Forces Analysis
Fig. 18 Attention Deficit Hyperactivity Disorder (ADHD) Drug Type Outlook: Key Takeaways
Fig. 19 Attention Deficit Hyperactivity Disorder Market: Drug Type Movement Analysis (USD Million)
Fig. 20 Stimulants Market 2018 - 2030 (USD Million)
Fig. 21 Amphetamine Market, 2018 - 2030 (USD Million)
Fig. 22 Methylphenidate Market, 2018 - 2030 (USD Million)
Fig. 23 Lisdexamfetamine Market, 2018 - 2030 (USD Million)
Fig. 24 Dexmethylphenidate Market, 2018 - 2030 (USD Million)
Fig. 25 Non - stimulants Market, 2018 - 2030 (USD Million)
Fig. 26 Atomoxetine Market, 2018 - 2030 (USD Million)
Fig. 27 Guanfacine Market, 2018 - 2030 (USD Million)
Fig. 28 Clonidine Market, 2018 - 2030 (USD Million)
Fig. 29 Others Market, 2018 - 2030 (USD Million)
Fig. 30 Attention Deficit Hyperactivity Disorder Demographic Outlook: Key Takeaways
Fig. 31 Attention Deficit Hyperactivity Disorder Market: Demographic Movement Analysis (USD Million)
Fig. 32 Children (2 - 17 years) Market, 2018 - 2030 (USD Million)
Fig. 33 Adult Market, 2018 - 2030 (USD Million)
Fig. 34 Attention Deficit Hyperactivity Disorder Distribution Channel Outlook: Key Takeaways
Fig. 35 Attention Deficit Hyperactivity Disorder Market: Distribution Channel Analysis (USD Million)
Fig. 36 Retail Pharmacy Market, 2018 - 2030 (USD Million)
Fig. 37 Hospital Pharmacy Market, 2018 - 2030 (USD Million)
Fig. 38 Regional Snapshot, 2022 & 2030
Fig. 39 Regional Market Place: Key takeaways
Fig. 40 North America
Fig. 41 North America Attention Deficit Hyperactivity Disorder (ADHD) Market, 2018 - 2030 (USD million)
Fig. 42 U.S.
Fig. 43 U.S. Attention Deficit Hyperactivity Disorder (ADHD) Market, 2018 - 2030 (USD Million)
Fig. 44 Canada
Fig. 45 Canada Attention Deficit Hyperactivity Disorder (ADHD) Market, 2018 - 2030 (USD million)
Fig. 46 Europe
Fig. 47 Europe Attention Deficit Hyperactivity Disorder (ADHD) Market, 2018 - 2030 (USD Million)
Fig. 48 U.K.
Fig. 49 U.K. Attention Deficit Hyperactivity Disorder (ADHD) Market, 2018 - 2030 (USD Million)
Fig. 50 Germany
Fig. 51 Germany Attention Deficit Hyperactivity Disorder (ADHD) Market, 2018 - 2030 (USD Million)
Fig. 52 Spain
Fig. 53 Spain Attention Deficit Hyperactivity Disorder (ADHD) Market, 2018 - 2030 (USD Million)
Fig. 54 France
Fig. 55 France Attention Deficit Hyperactivity Disorder (ADHD) Market, 2018 - 2030 (USD Million)
Fig. 56 Italy
Fig. 57 Italy Attention Deficit Hyperactivity Disorder (ADHD) Market, 2018 - 2030 (USD Million)
Fig. 58 Asia Pacific
Fig. 59 Asia Pacific Attention Deficit Hyperactivity Disorder (ADHD) Market, 2018 - 2030 (USD Million)
Fig. 60 Japan
Fig. 61 Japan Attention Deficit Hyperactivity Disorder (ADHD) Market, 2018 - 2030 (USD Million)
Fig. 62 China
Fig. 63 China Attention Deficit Hyperactivity Disorder (ADHD) Market, 2018 - 2030 (USD Million)
Fig. 64 India
Fig. 65 India Attention Deficit Hyperactivity Disorder (ADHD) Market, 2018 - 2030 (USD Million)
Fig. 66 Australia
Fig. 67 Australia Attention Deficit Hyperactivity Disorder (ADHD) Market, 2018 - 2030 (USD Million)
Fig. 68 South Korea
Fig. 69 South Korea Attention Deficit Hyperactivity Disorder (ADHD) Market, 2018 - 2030 (USD Million)
Fig. 70 Latin America
Fig. 71 Latin America Attention Deficit Hyperactivity Disorder (ADHD) Market, 2018 - 2030 (USD Million)
Fig. 72 Brazil
Fig. 73 Brazil Attention Deficit Hyperactivity Disorder (ADHD) Market, 2018 - 2030 (USD Million)
Fig. 74 Mexico
Fig. 75 Mexico Attention Deficit Hyperactivity Disorder (ADHD) Market, 2018 - 2030 (USD Million)
Fig. 76 Argentina
Fig. 77 Argentina Attention Deficit Hyperactivity Disorder (ADHD) Market, 2018 - 2030 (USD Million)
Fig. 78 Middle East & Africa
Fig. 79 MEA Attention Deficit Hyperactivity Disorder (ADHD) Market, 2018 - 2030 (USD Million)
Fig. 80 South Africa
Fig. 81 South Africa Attention Deficit Hyperactivity Disorder (ADHD) Market, 2018 - 2030 (USD Million)
Fig. 82 Saudi Arabia
Fig. 83 Saudi Arabia Attention Deficit Hyperactivity Disorder (ADHD) Market, 2018 - 2030 (USD Million)
Fig. 84 UAE
Fig. 85 UAE Attention Deficit Hyperactivity Disorder (ADHD) Market, 2018 - 2030 (USD Million)
Fig. 86 Heat Map Analysis
Fig. 87 Company Market Position Analysis, 2022
Fig. 88 Company Market Position Analysis, 2022
Fig. 89 Company Market Share Analysis (2022)
Fig. 90 Consumer Behavior Analysis
Fig. 91 Market Differentiators

Companies Mentioned

  • Pfizer, Inc.
  • Johnson & Johnson Services, Inc.
  • Lupin
  • Novartis AG
  • Takeda Pharmaceutical Company Limited
  • Mallinckrodt plc.
  • Purdue Pharma L.P.
  • Neos Therapeutics, Inc.
  • Supernus Pharmaceuticals, Inc.

Methodology

Loading
LOADING...

Related Topics

Related Reports

Attention Deficit Hyperactivity Disorder Market - Product Image

Attention Deficit Hyperactivity Disorder Market

  • Report
  • 119 Pages
  • Global
From
Global Attention Deficit Hyperactivity Disorder Market Size, Share & Industry Trends Analysis Report By Drug Type, By Demographics (Adults and Children), By Distribution Channel (Retail Pharmacy and Hospital Pharmacy), By Regional Outlook and Forecast, 2022 - 2028 - Product Image

Global Attention Deficit Hyperactivity Disorder Market Size, Share & Industry Trends Analysis Report By Drug Type, By Demographics (Adults and Children), By Distribution Channel (Retail Pharmacy and Hospital Pharmacy), By Regional Outlook and Forecast, 2022 - 2028

  • Report
  • 294 Pages
  • Global
From
Attention Deficit Hyperactivity Disorder Market by Drug Type, Demographics, Distribution Channel, and by Region - Global Forecast to 2022-2033 - Product Image

Attention Deficit Hyperactivity Disorder Market by Drug Type, Demographics, Distribution Channel, and by Region - Global Forecast to 2022-2033

  • Report
  • 200 Pages
  • Global
From
Attention Deficit Hyperactivity Disorder Treatment Market, by Drug Type, by Age Group, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 - Product Image

Attention Deficit Hyperactivity Disorder Treatment Market, by Drug Type, by Age Group, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

  • Report
  • 181 Pages
  • Global
From
Asia Pacific Attention Deficit Hyperactivity Disorder Market Size, Share & Industry Trends Analysis Report By Drug Type, By Demographics (Adults and Children), By Distribution Channel (Retail Pharmacy and Hospital Pharmacy), By Country and Growth Forecast, 2022 - 2028 - Product Image

Asia Pacific Attention Deficit Hyperactivity Disorder Market Size, Share & Industry Trends Analysis Report By Drug Type, By Demographics (Adults and Children), By Distribution Channel (Retail Pharmacy and Hospital Pharmacy), By Country and Growth Forecast, 2022 - 2028

  • Report
  • 111 Pages
  • Asia Pacific
From
Copyright © 2002-2023 Research and Markets. All Rights Reserved.